新規登録 | ログイン | FAQ      [?] 

タグ: chemotherapy [59 articles]

Recent papers classified by the tag chemotherapy.
  • <I>In vivo</I> MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft
    NMR in Biomedicine, Vol. 9999, No. 9999. (2008), n/a.
    by Seung-Cheol Lee, Ming Q Huang, David S Nelson, Stephen Pickup, Suzanne Wehrli, Onikepe Adegbola, Harish Poptani, Edward J Delikatny, Jerry D Glickson
    posted to xenograft mr-spectro lymphoma chemotherapy by xtizon on 2008-04-27 21:58:50 as **
  • Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.
    Neoplasia, Vol. 6, No. 6. (c 2004), pp. 831-837.
    posted to breast cancer chemotherapy dw-mri by xtizon on 2008-02-22 10:07:08 as ****
  • MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms
    NMR in Biomedicine, Vol. 9999, No. 9999. (2007), n/a.
    by David L Morse, Jean-Philippe Galons, Claire M Payne, Dominique L Jennings, Sam Day, Guowei Xia, Robert J Gillies
    posted to apoptosis chemotherapy dw-mri by xtizon on 2007-08-21 13:16:03 as *****
  • Patterns of fatigue during a course of chemotherapy: Results from a multi-centre study.
    Eur J Oncol Nurs (27 June 2006)
    by Morven Miller, Roma Maguire, Nora Kearney
    posted to chemotherapy fatigue pattern by wumeisi on 2006-07-02 08:25:51 as **
  • Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity.
    J Androl, Vol. 28, No. 2. (r 2007), pp. 241-249.
    by G Delbes, BF Hales, B Robaire
    posted to chemotherapy dna_damage rat scsa sperm_chromatin spermatozoa by uz_labu_laimi on 2007-03-21 03:30:51 as **
  • Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential.
    J Biol Chem, Vol. 268, No. 4. (5 February 1993), pp. 2649-2654.
    by F Larminat, W Zhen, VA Bohr
  • The nuclear matrix as a site of anticancer drug action.
    Int Rev Cytol, Vol. 162A (1995), pp. 539-576.
  • The role of the nuclear matrix in cancer chemotherapy.
    Crit Rev Eukaryot Gene Expr, Vol. 9, No. 3-4. (1999), pp. 337-343.
    by HJ Muenchen, KJ Pienta
    posted to cancer chemotherapy nuclear_matrix review by uz_labu_laimi on 2007-03-08 03:33:41 as **
  • DNA and the chromosome – varied targets for chemotherapy
    Cell & Chromosome, Vol. 3 (24 May 2004), 2.
    by Stephanie M Nelson, Lynnette R Ferguson, William A Denny
  • Adjuvant Post-operative Chemotherapy in Bitches with Mammary Cancer
    Journal of Veterinary Medicine Series A, Vol. 48, No. 2. (2001), pp. 85-96.
    posted to chemotherapy dog mammary neoplasia by szago on 2007-10-27 15:16:29 as **
  • Combination Chemotherapy in Feline Lymphoma: Treatment Outcome, Tolerability, and Duration in 23 Cats
    Journal of Veterinary Internal Medicine, Vol. 22, No. 2. (2008), pp. 394-400.
    by D Simon, N Eberle, Laacke L Singer, I Nolte
    posted to lymphoma chemotherapy cat by szago on 2008-06-26 08:26:36 as **
  • Pulmonary oedema as a suspected adverse drug reaction following vincristine administration to a cat: A case report
    The Veterinary Journal, Vol. In Press, Corrected Proof
    by Gerry A Polton, Clive M Elwood
    posted to cat chemotherapy cll neoplasia by szago on 2007-10-27 15:56:37 as **
  • RESPONSE OF NINETEEN CATS WITH NASAL LYMPHOMA TO RADIATION THERAPY AND CHEMOTHERAPY
    Veterinary Radiology & Ultrasound, Vol. 48, No. 4. (2007), pp. 388-393.
    by Gabriella Sfiligoi, Alain P Theon, Michael S Kent
  • Endoscopic ultrasound-guided interstitial chemotherapy in the pancreas: results in a canine model.
    Endoscopy, Vol. 39, No. 6. (June 2007), pp. 530-534.
    by S Sun, S Wang, N Ge, T Lei, Q Lu, Z Zhou, A Yang, Z Wang, M Sun
  • Expanding role of the medical oncologist in the management of head and neck cancer.
    CA Cancer J Clin, Vol. 58, No. 1. (b 2008), pp. 32-53.
    by N Choong, E Vokes
    posted to chemotherapy headneck medical oncologist review by shl on 2008-01-27 16:52:17 as **
  • Serial evaluation of patients with brain tumors using volume MRI and 3D <SUP><FONT SIZE='-1'>1</FONT></SUP>H MRSI
    NMR in Biomedicine, Vol. 12, No. 3. (1999), pp. 123-138.
    by Sarah J Nelson, Daniel B Vigneron, William P Dillon
  • pH and chemotherapy.
    Novartis Found Symp, Vol. 240 (2001)
    posted to chemotherapy ph by samoday on 2006-06-14 11:24:40 as **
  • Noninvasive imaging of anticancer therapy.
    Mol Cancer Ther, Vol. 2, No. 3. (March 2003), pp. 333-334.
    by RJ Gillies
    posted to apoptosis cancer chemotherapy nmr by samoday on 2006-06-14 11:23:09 as **
  • Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.
    Biochem Pharmacol, Vol. 66, No. 7. (1 October 2003), pp. 1219-1229.
    posted to cancer chemotherapy ph by samoday on 2006-06-14 11:21:33 as **
  • Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro.
    Biochem Pharmacol, Vol. 66, No. 7. (1 October 2003), pp. 1207-1218.
    posted to cancer chemotherapy ph by samoday on 2006-06-14 11:21:01 as **
  • notes PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin's Disease
    J Nucl Med, Vol. 43, No. 8. (1 August 2002), pp. 1018-1027.
    by Lale Kostakoglu, Morton Coleman, John P Leonard, Ichiei Kuji, Holly Zoe, Stanley J Goldsmith
    posted to chemotherapy glycolysis lymphoma paper1 pet treatment-response by samoday on 2007-03-24 13:24:00 as **
  • Apoptosis in murine tumors treated with chemotherapy agents.
    Anticancer Drugs, Vol. 6, No. 3. (June 1995), pp. 443-450.
    by RE Meyn, LC Stephens, NR Hunter, L Milas
    posted to apoptosis chemotherapy treatment-response by samoday on 2006-06-26 10:30:48 as **
  • Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.
    Cancer J, Vol. 9, No. 1. (b 2003), pp. 33-41.
    posted to apoptosis bcl2 chemotherapy treatment-response by samoday on 2006-06-26 10:27:58 as **
  • Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
    Cancer, Vol. 89, No. 11. (2000), pp. 2145-2152.
    by J Chang, M Ormerod, TJ Powles, DC Allred, SE Ashley, M Dowsett
    posted to apoptosis chemotherapy treatment-response by samoday on 2006-06-26 10:23:26 as **
  • Applications of MRS in the evaluation of focal malignant brain lesions.
    Cancer Imaging, Vol. 6 (2006), pp. 95-99.
    by S Delorme, MA Weber
    posted to brain cancer chemotherapy glioma hypoxia lactate mrs nmr treatment-response by samoday on 2007-08-16 12:38:50 as **
  • Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
    Cancer Treatment Reviews, Vol. 29, No. 6. (December 2003), pp. 541-549.
    by Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Hidetaka Uramoto, Yoichiro Yoshida, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Takeshi Yoshida, Minoru Nomoto, Kimitoshi Kohno
    posted to cancer chemotherapy lactate mct ph by samoday on 2006-08-02 08:50:57 as **
  • Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.
    Mol Imaging, Vol. 3, No. 1. (January 2004), pp. 1-8.
    by SJ Mandl, C Mari, M Edinger, RS Negrin, JF Tait, CH Contag, FG Blankenberg
    posted to apoptosis chemotherapy pet phosphatidylserine treatment-response by samoday on 2006-08-07 11:16:31 as **
  • notes Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review
    The Lancet Oncology, Vol. 5, No. 9. (September 2004), pp. 531-540.
    by Johan Vansteenkiste, Barbara M Fischer, Christophe Dooms, Jann Mortensen
    posted to chemotherapy lung-cancer paper1 pet treatment-response by samoday on 2007-03-24 13:27:34 as **
  • Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non Small-Cell Lung Cancer Guideline
    J Clin Oncol, Vol. 25, No. 34. (1 December 2007), pp. 5506-5518.
    by Katherine M Pisters, William K Evans, Christopher G Azzoli, Mark G Kris, Christopher A Smith, Christopher E Desch, Mark R Somerfield, Melissa C Brouwers, Gail Darling, Peter M Ellis, Laurie E Gaspar, Harvey I Pass, David R Spigel, John R Strawn, Yee C Ung, Frances A Shepherd
  • notes Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Brain, Vol. 130, No. Pt 4. (April 2007), pp. 1076-1088.
    posted to chemotherapy cisplatin dying-back neuropathy sensory by Oyinlola on 2007-05-30 14:53:49 as read
  • Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: Effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.
    Exp Neurol (17 November 2007)
    by Hai Wei W Jin, Sarah J L J Flatters, Wen Hua H Xiao, Howard L L Mulhern, Gary J J Bennett
    posted to chemotherapy mechanism mitochondria pain by Oyinlola on 2008-01-14 17:13:59 as ***
  • Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
    N Engl J Med, Vol. 352, No. 10. (10 March 2005), pp. 987-996.
  • Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy.
    J Neurosurg, Vol. 100, No. 1. (January 2004), pp. 41-46.
    by GE Keles, KR Lamborn, SM Chang, MD Prados, MS Berger
    posted to chemotherapy glioma by monimonicas on 2008-02-20 17:41:02 as **
  • Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.
    Lancet, Vol. 359, No. 9311. (23 March 2002), pp. 1011-1018.
    by LA Stewart
    posted to chemotherapy glioma by monimonicas on 2008-02-20 18:19:13 as **
  • Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.
    Br J Cancer, Vol. 74, No. 9. (November 1996), pp. 1487-1491.
    by MH Cullen, LJ Billingham, J Cook, CM Woodroffe
    posted to cancer chemotherapy crctu firemen patient-choice surveillance testis by mgp28 on 2007-10-29 16:06:38 as read
  • Obesity in Dose Calculation: A Mouse or an Elephant?
    J Clin Oncol, Vol. 25, No. 30. (20 October 2007), pp. 4703-4704.
    by Howard Gurney, Rachel Shaw
    posted to chemotherapy general by lrust on 2008-01-27 00:07:36 as **
  • Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
    Chest, Vol. 132, No. 3 Suppl. (September 2007)
    by GR Simon, A Turrisi,
    posted to chemotherapy sclc by Kyaita on 2008-01-26 17:06:39 as **
  • Small cell lung cancer: have we made any progress over the last 25 years?
    Oncologist, Vol. 12, No. 9. (September 2007), pp. 1096-1104.
    by BE Lally, JJ Urbanic, AW Blackstock, AA Miller, MC Perry
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:53:25 as **
  • Effectiveness of intensive follow-up after response in patients with small cell lung cancer.
    Lung Cancer (25 September 2007)
    by Tomohide Sugiyama, Takashi Hirose, Takamichi Hosaka, Sojiro Kusumoto, Masanao Nakashima, Toshimitsu Yamaoka, Kentaro Okuda, Tohru Ohmori, Mitsuru Adachi
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:49:50 as **
  • Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.
    Ann Oncol, Vol. 19, No. 1. (January 2008), pp. 123-127.
    by DH Lee, SW Kim, C Suh, JS Lee, JH Lee, SJ Lee, BY Ryoo, K Park, JS Kim, DS Heo, NK Kim
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:48:33 as **
  • Management of small cell lung cancer.
    Evid Rep Technol Assess (Full Rep), No. 143. (July 2006), pp. 1-154.
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:43:13 as **
  • Current status of second-line treatment and novel therapies for small cell lung cancer.
    J Thorac Oncol, Vol. 2, No. 8. (August 2007), pp. 764-772.
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:39:58 as **
  • Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer.
    J Thorac Oncol, Vol. 2, No. 8. (August 2007), pp. 741-744.
    by S Igawa, N Yamamoto, S Ueda, A Ono, Y Nakamura, A Tsuya, H Murakami, M Endo, T Takahashi
    posted to amr chemotherapy sclc by Kyaita on 2008-01-26 16:33:03 as **
  • [A case of relapsed small-cell lung cancer successfully treated by administration of amrubicin]
    Nihon Kokyuki Gakkai Zasshi, Vol. 45, No. 12. (December 2007), pp. 967-970.
    by H Mori, H Tanaka
    posted to chemotherapy sclc by Kyaita on 2008-01-26 16:24:42 as **
  • Chemotherapy-Induced Nausea and Vomiting
    N Engl J Med, Vol. 358, No. 23. (5 June 2008), pp. 2482-2494.
    by Paul J Hesketh
    posted to vomiting chemotherapy by jyuh on 2008-06-05 04:48:55 as ** along with 2 people Amazoness eisei
  • Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats.
    Fertil Steril, Vol. 81 Suppl 1 (March 2004), pp. 842-849.
    posted to apoptosis cancer chemotherapy treatment by jjohnson17 on 2007-10-10 18:13:06 as **
  • The FK506 binding protein Fpr3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity.
    Cell, Vol. 122, No. 6. (23 September 2005), pp. 861-873.
    by A Hochwagen, WH Tham, GA Brar, A Amon
    posted to checkpoint chemotherapy recombination tor by jjohnson17 on 2008-03-05 20:56:47 as *****
  • Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
    Proceedings of the National Academy of Sciences (31 March 2008), 0708100105.
    by Lizzia Raffaghello, Changhan Lee, Fernando M Safdie, Min Wei, Federica Madia, Giovanna Bianchi, Valter D Longo
  • Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    J Clin Oncol, Vol. 24, No. 3. (20 January 2006), pp. 419-430.
    by M McCulloch, C See, XJ Shu, M Broffman, A Kramer, WY Fan, J Gao, W Lieb, K Shieh, JM Colford
    posted to astralagus chemotherapy by anihawkinson to the group Nutritional_Polymorphisms on 2006-07-19 22:05:42 as **
  • EGFR antagonists in cancer treatment.
    N Engl J Med, Vol. 358, No. 11. (13 March 2008), pp. 1160-1174.
    posted to oral egfr chemotherapy antagonists by dfp7582 on 2008-05-12 20:16:40 as ** along with 1 person jyuh
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/chemotherapy

    Result page: 1 2 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.